Latest "Placebo Hepatitis Virus Infection" News Stories

13:03 EDT 4th July 2015 | BioPortfolio

Here are the most relevant search results for "Placebo Hepatitis Virus Infection" found in our extensive news archives from over 250 global news sources.

More Information about Placebo Hepatitis Virus Infection on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Placebo Hepatitis Virus Infection for you to read. Along with our medical data and news we also list Placebo Hepatitis Virus Infection Clinical Trials, which are updated daily. BioPortfolio also has a large database of Placebo Hepatitis Virus Infection Companies for you to search.

Showing "Placebo Hepatitis Virus Infection" News Articles 1–25 of 7,300+

Extremely Relevant

Hepatitis C and HIV Co-infection Closing the Gaps

Hepatitis C virus (HCV) infection causes substantial morbidity and mortality, but patients with human immunodeficiency virus (HIV) co-infection are 3 times more likely to develop cirrhosis or liver decompensation than those infected with hepatitis C ...

Hepatitis B Virus exposure matures infants' immune systems

Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical in...

[Review] Resistance to hepatitis C virus: potential genetic and immunological determinants

Studies of individuals who were highly exposed but seronegative (HESN) for HIV infection led to the discovery that homozygosity for the Δ32 deletion mutation in the CCR5 gene prevents viral entry into target cells, and is associated with resistance ...

Study builds understanding of hepatitis C virus replication

Hepatitis C virus infection is a common cause of liver disease and of liver cancer in the United States. Through a new study that explores one aspect of how the virus hijacks host cell machinery to replicate itself, UNC Lineberger Comprehensive Cance...

Age-related hepatitis B infection and the gut microbiome

(Medical Xpress)—The hepatitis B virus (HBV), which affects the liver, behaves differently in different people depending on genetics and the age the person is when infected. Ninety-five percent of adults who contract hepatitis B clear the virus aft...

Lives Could Be Saved with New Hepatitis C Therapy

In a letter to the Medical Journal of Australia, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths. Hepatitis C virus (HCV) infection is a major public health burden in Australia, with estimates of 230,000 people chronically infected.

CDC Observes 20th Anniversary of Hepatitis Awareness Month

This month marks the 20th anniversary of Hepatitis Awareness Month and the 4th National Hepatitis Testing Day (May 19) in the United States. Although care and treatment can be life-saving, many of the 3 million persons estimated to be living with hepatitis C virus (HCV) infection are unaware of their infection and are not receiving preventive

Use of Antihistamine Compounds for the Treatment of Hepatitis C Virus

The vast majority of people infected with Hepatitis C Virus (HCV) will have chronic infection. Over decades, this can lead to liver disease and liver cancer. In fact, HCV infection is the leading cause of liver transplants in the U.S. Several new drugs have recently come into the market that will likely change the HCV treatment paradigm. However, the effectiveness of these new drugs c...

Alcohol use disorders - stronger predictor of mortality than chronic hepatitis C virus infection

(European Association for the Study of the Liver) Results presented today at The International Liver Congress™ 2015, show that alcohol use disorders (AUD) have a serious, negative prognostic outcome with higher mortality risks in the general popula...

Continued Progress Against Hepatitis C Infection

This Viewpoint describes clinical progress in eradicating hepatitis C virus infection, but emphasizes the importance of making treatment more cost-effective and accessible to all patients.

Hepatitis C and its impact on renal transplantation

Hepatitis C virus (HCV) infection imposes a substantial economic, clinical, and societal burden worldwide. In this Review, Morales and Fabrizi compare the treatment options that are available to patients with HCV infection, before and after renal tra...

Viekirax and Exviera for the Treatment of Chronic Hepatitis C Virus Infection

Viekirax (ombitasvir / paritaprevir / ritonavir) and Exviera (dasabuvir) is indicated for the treatment of genotype 1 chronic hepatitis C virus (HCV) infection and compensated cirrhosis.

Hepatitis: New mouse model provides novel insights into hepatitis D virus infection and clearance

[News] Possible link between hepatitis B infection and gastric cancer

Hepatitis B virus (HBV) infection might increase the risk of developing gastric cancer, according to the results of a new study.

Latest advances in hepatitis C therapy

The availability of new protease inhibitors is revolutionising the treatment of hepatitis C virus infection.

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

Inhibiting virus cell entry by targeting tight junctions cures HCV infection in mice.

Widespread hepatitis C screening may result in more harms than benefits

Several organizations have recommended scaling up screening for hepatitis C infection. But experts warn that no study has tested whether this will lead to net clinical benefit or harm. Hepatitis C is a virus that can infect and damage the liver.

Study Details MicroRNA's Role as a Double Agent During Hepatitis C Infection

In the battle between a cell and a virus, either side may resort to subterfuge. Molecular messages, which control the cellular machinery both sides need, are vulnerable to interception or forgery. New research at Rockefeller University has revealed the unique twist on just such a strategy deployed by the liver-infecting hepatitis C virus –

NIH Study Suggests Alternative Drug to Treat Hepatitis C Virus Infection

An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice, according to a National Institutes of Health study. The results suggest that the drug, chlorcyclizine HCl (CCZ), potentially could be used to treat the virus in people. Results were published April 8 in Science Translational Medicine.

HBV exposure matures infants' immune systems

A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radicall...

Hepatitis B Virus May Be Linked to Gastric Cancer

Hepatitis B virus (HBV) infection is associated with gastric cancer, particularly in patients without a family history of gastric cancer, researchers from China report. Reuters Health Information

Study details microRNA's role as double agent during Hep C infection

Once inside a liver cell, the hepatitis C virus must bind to miRNA-122 in order to establish a persistent infection. Researchers have now found an unanticipated consequence of this interaction: By using miRNA-122 for its own ends, the virus appears t...

Scientists Identify Crucial Step in Helping to Prevent Hepatitis C Virus Replication

New research from the University of Southampton has identified how changes in the cell membrane play a pivotal role in how the hepatitis C virus replicates. By understanding this process, the researchers hope to investigate how to prevent the changes and potentially develop therapeutic drugs to combat the hepatitis C virus (HCV), which infects an

Differences in Liver Cancer Attributable to Hepatitis Virus Variations

Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -- hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly

Study details microRNA's role as a double agent during Hep C infection

(Rockefeller University) Once inside a liver cell, the hepatitis C virus must bind to miRNA-122 in order to establish a persistent infection. Researchers at Rockefeller University found an unanticipated consequence of this interaction: By using miRNA...



Advertisement
 
Advertisement
 

News Quicklinks